- Home
- TOMZ vs ICU Comparison
TOMZ vs ICU Comparison
Compare TOMZ & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOMZ | ICU |
|---|---|---|
| Founded | 1979 | 2018 |
| Country | United States | United States |
| Employees | 20 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 13.8M |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TOMZ | ICU |
|---|---|---|
| Price | $1.57 | $3.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.9K | ★ 46.3K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.64 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,635,927.00 | $1,234,000.00 |
| Revenue This Year | $48.56 | $53.00 |
| Revenue Next Year | $121.37 | $50.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 814.07 |
| 52 Week Low | $0.50 | $0.22 |
| 52 Week High | $2.12 | $5.38 |
Technical Indicators
Market Signals| Indicator | TOMZ | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 42.93 | 43.72 |
| Support Level | $0.68 | $2.90 |
| Resistance Level | $1.95 | $3.50 |
| Average True Range (ATR) | 0.10 | 0.15 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 10.00 | 40.06 |
Price Performance
Historical ComparisonAbout TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.